Ovarian Cancer Clinical Trials
Find clinical trials for ovarian cancer. Search for ovarian cancer clinical trials in different cities and states across the United States.
TT-10 & TT-4TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors
Sponsor:
Portage Biotech
Location:
Code:
NCT04969315
Conditions
Renal Cell Cancer
Castrate Resistant Prostate Cancer
Non Small Cell Lung Cancer
Head and Neck Squamous Cell Carcinoma
Colorectal Cancer (CRC)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TT-10
TT-4
GI-102, Pembrolizumab, T-DXdA Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Sponsor:
GI Innovation, Inc.
Location:
Code:
NCT05824975
Conditions
Advanced Solid Tumor
Metastatic Solid Tumor
Soft Tissue Sarcoma (STS)
Platinum-resistant Ovarian Cancer (PROC)
Hepatocellular Carcinoma (HCC)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
GI-102 subcutaneous (SC)
GI-102
doxorubicin
paclitaxel
bevacizumab
Perioperative Stress ReductionA Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
Sponsor:
Memorial Sloan Kettering Cancer Center
Location:
Code:
NCT05429970
Conditions
Ovarian Cancer
Ovarian Carcinoma
Stage II Ovary Cancer
Stage II Ovarian Cancer
Stage III Ovary Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Mind-body resilience training
Music therapy
Propranolol
Etodolac
Observational StudyCirculating Tumor DNA Exposure in Peripheral Blood
Sponsor:
Quantgene Inc.
Location:
Code:
NCT03517332
Conditions
Colorectal Cancer
Pancreatic Adenocarcinoma
Gastric Cancer
Hepatocellular Carcinoma
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
CASIPilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
Sponsor:
Dana-Farber Cancer Institute
Location:
Code:
NCT06543537
Conditions
Ovarian Cancer
Ovarian Neoplasms
Ovarian Carcinoma
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Collaborative Agenda-Setting Intervention
ZEN003694 & TalazoparibZEN003694 Combined with Talazoparib in Patients with Recurrent Ovarian Cancer
Sponsor:
Alexander B Olawaiye, MD
Location:
Code:
NCT05071937
Conditions
Ovarian Cancer
Peritoneal Cancer
Fallopian Tube Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ZEN003694
Talazoparib
E7777 & PembrolizumabT-regulatory Cell Depletion with E7777 Combined with Pembrolizumab in Recurrent or Metastatic Solid Tumors
Sponsor:
Alexander B Olawaiye, MD
Location:
Code:
NCT05200559
Conditions
Epithelial Ovarian Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pembrolizumab
E7777
Cancer PreventionCancer Prevention in Women With a BRCA Mutation
Sponsor:
Women's College Hospital
Location:
Code:
NCT02225015
Conditions
BRCA1 Gene Mutation
BRCA2 Gene Mutation
Breast Cancer
Ovarian Cancer
Eligibility Criteria
Sex: Female
Age: 35 - 70
Healthy Volunteers: Not accepted
Interventions
Follow-up Telephone Genetic Counselling
BCA101Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Sponsor:
Bicara Therapeutics
Location:
Code:
NCT04429542
Conditions
Head and Neck Squamous Cell Carcinoma
Squamous Cell Carcinoma of Anal Canal
Colorectal Cancer
Squamous Cell Carcinoma of the Lung
EGFR Amplification
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BCA101
Pembrolizumab